We found that high expression of RNASEK was associated with good prognosis in PAAD patients (hazard ratio (HR): 0.49, P = 0.0007) (Figure 5A) and acute myeloid leukemia (LAML) patients (HR: 0.53, P = 0.029) (Appendix D). The gene discussed is RNASEK; the disease is pancreatic adenocarcinoma.